Valuing Health States for Use in Cost-Effectiveness Analysis

By Brazier John  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 769-779

Adis International

Access to resources Recommend Favorite

The cost-effectiveness of sertraline in the treatment of depression

By Olvey Eleanor L   Skrepnek Grant H  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 14, 2008-10 ,pp. : 2497-2508

Informa Healthcare

Access to resources Recommend Favorite

Use and Cost of Antiretrovirals in France 1995–2000: An Analysis Based on the Medical Dossier on Human Immunodeficiency (release 2) Database

By Flori Yves A.   Marc le Vaillant  

PharmacoEconomics, Vol. 22, Iss. 16, 2004-01 ,pp. : 1061-1070

Adis International

Access to resources Recommend Favorite

The Cost to the United Kingdom National Health Service of Managing Erectile Dysfunction: The Impact of Sildenafil and Prescribing Restrictions

By Wilson E.C.F.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 879-889

Adis International

Access to resources Recommend Favorite

Addiction Treatment History, Medical Services Utilization, and Cost A Longitudinal Analysis of Problem Drinkers

By Alexandre Pierre Kébreau   French Michael T.   Matzger Helen   Weisner Constance  

Journal of Addictive Diseases, Vol. 25, Iss. 1, 2006-03 ,pp. : 105-120

Haworth Press

Access to resources Recommend Favorite